Thrombophilia and fetal loss: Lessons from gene targeting in mice. Thromb Res 2009;123 Suppl 2:S79-84
Date
02/17/2009Pubmed ID
19217483DOI
10.1016/S0049-3848(09)70017-9Scopus ID
2-s2.0-65549169814 (requires institutional sign-in at Scopus site) 7 CitationsAbstract
Inherited thrombophilia is recognized as one of the causes of recurrent fetal loss. Yet, the risk of fetal loss in women with thrombophilia is far from absolute. Other risk modifiers are clearly involved, but remain to be identified. The mechanism that translates maternal thrombophilia into pregnancy disorder is also not understood. Genetically engineered mice have led to the development of new insights into the etiology and pathogenesis of thrombophilia-associated fetal loss. These insights are the focus of this review.
Author List
Sood RAuthor
Rashmi Sood PhD Associate Professor in the Pathology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AnimalsAnimals, Genetically Modified
Disease Models, Animal
Factor V
Female
Fetal Death
Humans
Mice
Mice, Knockout
Pregnancy
Pregnancy Complications, Hematologic
Thrombophilia